抗胺剂在喘管理中的有效性:一个批判性的科学分析
Ekta Verma1, Shweta Mishra2, Jeetendra Kumar Gupta3
1MET Faculty of Pharmacy, MIT, Moradabad, Uttar Pradesh, India.
Combinatorial chemistry & high throughput screening
|March 5, 2026
概括
抗胰岛素在过敏性喘管理中提供了显著的好处,减少了症状和皮质类固醇依赖. 新型化合物和自然疗法显示出改善喘控制和患者生活质量的承诺.
科学领域:
- 药理学 药理学是指药理学的学科.
- 免疫学 免疫学 免疫学
- 呼吸系统医学 呼吸系统医学
背景情况:
- 过敏性喘涉及过敏原和免疫球蛋白E (IgE) 的升高.
- 胰岛素是喘病因发生的关键媒介.
- 目前的喘治疗提供症状缓解,需要探索新的治疗途径.
研究的目的:
- 审查抗胺剂在喘管理中的当前作用.
- 评估药理学进步,自然疗法,以及用于喘的新型异环化合物.
- 评估抗组胺药除了症状缓解之外的治疗潜力.
主要方法:
- 在PubMed,ScienceDirect,Scopus和Web of Science中进行全面的文献搜索.
- 包括对抗胰岛素药物,草药化合物和合成喘衍生物的研究.
- 不包括非英语出版物,社论和缺乏初级数据的摘要.
主要成果:
- 第二代和第三代抗胰岛素可以缓解过敏喘症状,减少皮质类固醇的需要.
- 与白血受体对抗剂的联合治疗可以提高治疗效率.
- 异环化合物和植物衍生的植物化学物质显示出抗胰岛素和支气管扩展剂的潜力.
结论:
- 抗胰岛素作为有价值的支持性药物用于过敏性喘亚型.
- 现代抗胰岛素药物提供了更好的安全性,减少镇静和增加遵守.
- 多模式治疗策略,包括抗组胺剂,皮质类固醇和新型化合物,正在推进喘管理.
相关概念视频
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
2.1K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.1K
Antiasthma Drugs: Leukotriene Modifiers
2.1K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
2.1K
Antiasthma Drugs: β2-Adrenoceptor Agonists
1.9K
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
1.9K
Antiasthma Drugs: Muscarinic Receptor Antagonists
2.0K
Muscarinic receptor antagonists, also known as antimuscarinic agents, are a class of bronchodilators used to treat asthma, although they are more commonly used to treat COPD. They work by inhibiting the action of acetylcholine (ACh), a neurotransmitter, on muscarinic receptors found in the airways.
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
2.0K
Upper Respiratory Drugs: First and Second-Generation Antihistamines
1.5K
Antihistamines are a class of drugs widely used to alleviate the symptoms of allergies, such as sneezing, itching, and nasal congestion. They work by inhibiting the actions of histamine, which is released by immune cells in response to allergenic substances or tissue injuries.
Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...
Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...
1.5K
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
1.1K
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
1.1K


